Model 1 enables initial risk assessment using simple clinical parameters (e.g., previous antibiotic use, surgical history, and ulcer size), whereas Model 2 enhances predictive precision with the integration of CRP (AUC increased from 0.763 to 0.789). Here, CRP is linked to ulcer disease.